Abstract:Objective: To investigate the functional change of SRD5A2 gene mutations identified in patients with 5α-reductase type 2 deficiency. Patients and Methods: Three unrelated subjects born with ambiguous genitalia were included. All patients were initially reared as girls, but they gradually exhibited variable degrees of virilization at puberty without breast development, followed by a change of gender role. Sequencing analysis of the SRD5A2 gene was performed and enzymatic activities of 5α-reductase type 2 were a… Show more
“…Functional research exists already regarding the p.R227Q, p.G203S and p.R246Q mutation sites (10)(11)(12). To assess the functional effects of p.L20P and p.R62S, we performed in silico predictions.…”
In Chinese patients, SRD5A2 gene mutations were, relatively, frequently associated with hypospadias. The SF-1 gene may be another candidate gene for hypospadias. In contrast, AR gene mutations are not commonly associated with this condition.
“…Functional research exists already regarding the p.R227Q, p.G203S and p.R246Q mutation sites (10)(11)(12). To assess the functional effects of p.L20P and p.R62S, we performed in silico predictions.…”
In Chinese patients, SRD5A2 gene mutations were, relatively, frequently associated with hypospadias. The SF-1 gene may be another candidate gene for hypospadias. In contrast, AR gene mutations are not commonly associated with this condition.
“…The p.G203S mutation, the most frequent mutation found in this study, has been repeatedly reported in patients from East Asia, including China, Korea and Thailand, as well as Mexico . In vitro functional assay revealed that the enzymatic activity was retained in approximately 40% of the cases . Therefore, patients heterozygous for this mutation have been reported to have a more masculine phenotype in previous investigations .…”
Section: Discussionmentioning
confidence: 99%
“…The R227Q mutation, identified in patient 2, has been reported to significantly reduce 5α‐reductase activity to 3·2% in vitro and has only been reported in Asian patients from China, Vietnam, Japan, Mongolia and Laos . The p.Q6X mutation detected in patient 11 was first identified in a Japanese individual and has only been reported in patients from East Asian countries . The p.N193S mutation, carried by patient 5, has been reported in patients of Spanish, African and Chinese origin .…”
Section: Discussionmentioning
confidence: 99%
“…The nucleotide variation p.V89L and the frameshift mutation c.655delT were identified in patient 1, who presented with a nearly complete male phenotype and a micropenis. It was demonstrated that the c.655delT mutation caused a translational frameshift at codon 219 of the SRD5A2 gene, leading to a nearly complete loss of enzymatic activity . The variant p.V89L is considered to be one of the susceptibility factors for hypospadias and may lead to impairment in normal virilization of the external genitalia, although no discernible effect on the development of micropenis has reportedly been observed .…”
This cohort study describes the phenotypic, biochemical and long-term outcome in 11 Chinese patients with 5α-RD2 deficiency and defines the genotypic spectrum of SRD5A2 mutations in China.
“…The elevated T/DHT ratio post-HCG stimulation is more sensitive and reliable in diagnosis of 5a-RD3 and helpful to distinguish between androgen insensitive syndrome and other conditions arising from T synthesis defects. The diagnostic cut-off point of T/DHT ratio has not been precisely defined, varied from 3.6 to 18 in diverse ethnic groups pre or after HCG stimulation 456. Obviously, high T/DHT ratio of 26.4 after HCG stimulation is another reason for the diagnosis of mild 5a-RD.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.